Historical information
Respiratory tract infections are among the most common diseases both in adults and children. ………….Lantigen B is an oral product based on bacterial lysates of six different inactivated strains commonly involved in respiratory tract infections. ……….This study demonstrates Lantigen B's effectiveness in the prevention of bacterial complications and suggests that it can be used in patients who are particularly at risk of infection (children, the elderly, diabetics, and immunocompromised patients) or those in whom an infection might aggravate a clinical picture that is already inherently complicated (diabetics again, but also patients with heart, kidney, or liver disease).
https://www.researchgate.net/publication/8349012_Efficacy_of_Lantigen_B_in_the_prevention_of_bacterial_respiratory_infections
Significance
The control of respiratory conditions is essential to public health.
Physical description
Cardboard box containing a glass bottle of Lantigen colloidal mixture.
Inscriptions & markings
Lantigen. For the treatment of catarrah, chronic bronchitis and bronchial asthma. Edinburgh Laboratories, 103 York Street, Sydney, Australia. Bacterial Vaccine.
Subjects
References
- Efficacy of Lantigen B in the prevention of bacterial respiratory infections A study of the efficacy of Lantigen B.